These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

326 related items for PubMed ID: 9716183

  • 1. Activation of the mitogen-activated protein kinase pathway in U937 leukemic cells induces phosphorylation of the amino terminus of the TATA-binding protein.
    Biggs JR, Ahn NG, Kraft AS.
    Cell Growth Differ; 1998 Aug; 9(8):667-76. PubMed ID: 9716183
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Constitutively active MAP kinase kinase (MEK1) stimulates SAP kinase and c-Jun transcriptional activity in U937 human leukemic cells.
    Franklin CC, Kraft AS.
    Oncogene; 1995 Dec 07; 11(11):2365-74. PubMed ID: 8570188
    [Abstract] [Full Text] [Related]

  • 4. MEK1 and the extracellular signal-regulated kinases are required for the stimulation of IL-2 gene transcription in T cells.
    Whitehurst CE, Geppert TD.
    J Immunol; 1996 Feb 01; 156(3):1020-9. PubMed ID: 8557975
    [Abstract] [Full Text] [Related]

  • 5. A dominant role for the Raf-MEK pathway in forskolin, 12-O-tetradecanoyl-phorbol acetate, and platelet-derived growth factor-induced CREB (cAMP-responsive element-binding protein) activation, uncoupled from serine 133 phosphorylation in NIH 3T3 cells.
    Seternes OM, Johansen B, Moens U.
    Mol Endocrinol; 1999 Jul 01; 13(7):1071-83. PubMed ID: 10406459
    [Abstract] [Full Text] [Related]

  • 6. The mitogen-activated protein kinase pathway inhibits ceramide-induced terminal differentiation of a human monoblastic leukemia cell line, U937.
    Ragg SJ, Kaga S, Berg KA, Ochi A.
    J Immunol; 1998 Aug 01; 161(3):1390-8. PubMed ID: 9686602
    [Abstract] [Full Text] [Related]

  • 7. Serotonergic repression of mitogen-activated protein kinase control of the calcitonin gene-related peptide enhancer.
    Durham PL, Russo AF.
    Mol Endocrinol; 1998 Jul 01; 12(7):1002-9. PubMed ID: 9658404
    [Abstract] [Full Text] [Related]

  • 8. The cyclin-dependent kinase inhibitor (CDKI) flavopiridol disrupts phorbol 12-myristate 13-acetate-induced differentiation and CDKI expression while enhancing apoptosis in human myeloid leukemia cells.
    Cartee L, Wang Z, Decker RH, Chellappan SP, Fusaro G, Hirsch KG, Sankala HM, Dent P, Grant S.
    Cancer Res; 2001 Mar 15; 61(6):2583-91. PubMed ID: 11289135
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The mitogen-activated protein kinase phosphatases PAC1, MKP-1, and MKP-2 have unique substrate specificities and reduced activity in vivo toward the ERK2 sevenmaker mutation.
    Chu Y, Solski PA, Khosravi-Far R, Der CJ, Kelly K.
    J Biol Chem; 1996 Mar 15; 271(11):6497-501. PubMed ID: 8626452
    [Abstract] [Full Text] [Related]

  • 11. Prolonged activation of the mitogen-activated protein kinase pathway is required for macrophage-like differentiation of a human myeloid leukemic cell line.
    Hu X, Moscinski LC, Valkov NI, Fisher AB, Hill BJ, Zuckerman KS.
    Cell Growth Differ; 2000 Apr 15; 11(4):191-200. PubMed ID: 10775036
    [Abstract] [Full Text] [Related]

  • 12. Mek1 phosphorylation site mutants activate Raf-1 in NIH 3T3 cells.
    Alessandrini A, Greulich H, Huang W, Erikson RL.
    J Biol Chem; 1996 Dec 06; 271(49):31612-8. PubMed ID: 8940180
    [Abstract] [Full Text] [Related]

  • 13. Insulin-induced c-Jun N-terminal kinase activation is negatively regulated by protein kinase C delta.
    Morino K, Maegawa H, Fujita T, Takahara N, Egawa K, Kashiwagi A, Kikkawa R.
    Endocrinology; 2001 Jun 06; 142(6):2669-76. PubMed ID: 11356718
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Divergent effects of bryostatin 1 and phorbol myristate acetate on cell cycle arrest and maturation in human myelomonocytic leukemia cells (U937).
    Vrana JA, Saunders AM, Chellappan SP, Grant S.
    Differentiation; 1998 May 06; 63(1):33-42. PubMed ID: 9615391
    [Abstract] [Full Text] [Related]

  • 16. The transcription factor GATA4 is activated by extracellular signal-regulated kinase 1- and 2-mediated phosphorylation of serine 105 in cardiomyocytes.
    Liang Q, Wiese RJ, Bueno OF, Dai YS, Markham BE, Molkentin JD.
    Mol Cell Biol; 2001 Nov 06; 21(21):7460-9. PubMed ID: 11585926
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Catalytic activation of mitogen-activated protein (MAP) kinase phosphatase-1 by binding to p38 MAP kinase: critical role of the p38 C-terminal domain in its negative regulation.
    Hutter D, Chen P, Barnes J, Liu Y.
    Biochem J; 2000 Nov 15; 352 Pt 1(Pt 1):155-63. PubMed ID: 11062068
    [Abstract] [Full Text] [Related]

  • 19. Gastrin and phorbol 12-myristate 13-acetate regulate the human histidine decarboxylase promoter through Raf-dependent activation of extracellular signal-regulated kinase-related signaling pathways in gastric cancer cells.
    Höcker M, Henihan RJ, Rosewicz S, Riecken EO, Zhang Z, Koh TJ, Wang TC.
    J Biol Chem; 1997 Oct 24; 272(43):27015-24. PubMed ID: 9341140
    [Abstract] [Full Text] [Related]

  • 20. Delay in serum stimulation of Erk activity caused by oncogenic transformation.
    Greulich H, Reichman C, Hanafusa H.
    Oncogene; 1996 Apr 18; 12(8):1689-95. PubMed ID: 8622889
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.